Leadership
We are a small team of PhD scientists, and we run the work ourselves.
BiocheMichael Industries now operates as Lodgepole Discovery. It is the same team and the same legal entity, and every agreement already in place stands unchanged.
Michael Holden, PhD
PhD in Chemistry from the University of Denver, where his doctoral work was on tau fibrils. Contributed to IND-stage antibody programs at Prothena, antibody discovery at Regeneron, and built the antibody-to-ADC platform as Head of Chemistry at BioLoomics. Visiting Scholar at the University of Denver.
Mike Minson, PhD
Cellular biochemist and molecular biologist with a PhD from the University of Colorado Boulder. Previously NGS assay design and validation for FDA submission at ArcherDx, antibody and exosome platform work at Sartorius, and synthetic biology lead at BioLoomics, running binding, internalization and killing assays across ADC discovery campaigns. He holds a selective Plasmidsaurus Fellowship for AI protein design.
Doug Hattendorf, PhD
Protein scientist turned business builder, trained at the University of Chicago and Stanford. He ran protein bench science at Codexis and founded the enzyme engineering team at Zymergen, then moved to the commercial side, leading business development at Ginkgo Bioworks and GeneFab.